May 10, 2019 10:44 AM EDT
Editor's note
Bioregnum
Opinion

That feel­ing you get when you hit the fin­ish line, and then set new goals

Self-con­grat­u­la­tion is an art form most of us mas­ter at an ear­ly age. And I’m no dif­fer­ent from your av­er­age per­son.

Like every­one, I un­der­stand …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Take­da to pay $200M for rights to ane­mia drug from Keros

Ipsen se­cures rights to pre­clin­i­cal T cell en­gager in $610M pact with French biotech

Rev­o­lu­tion sells $600M in shares on back of RAS in­hibitor port­fo­lio up­dates

Janux soars on ear­ly prostate can­cer da­ta that could chal­lenge No­var­tis' Plu­vic­to

Roche teams up with Chica­go au­toim­mune biotech COUR Phar­ma­ceu­ti­cals

Gilead makes an­oth­er ADC move, ink­ing up to $415M pact with Tubu­lis

A service from the Financial Times